Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04486989
Other study ID # 1R15DC017014-01A1
Secondary ID 0819.1s-ETSU
Status Completed
Phase N/A
First received
Last updated
Start date February 4, 2020
Est. completion date June 6, 2023

Study information

Verified date November 2023
Source East Tennessee State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Teachers are a population at high risk for voice disorders given their occupational demands. In a teaching career, a common debilitating symptom among all vocal symptoms experienced is - vocal fatigue, impacting teachers' occupational performance and increasing health care costs. It is therefore essential to identify potential treatment options to alleviate the symptom of vocal fatigue. The purpose of this study is to utilize a body-system level cardiovascular training protocol in comparison to traditional voice production training to alleviate the symptoms of vocal fatigue.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date June 6, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria: - Female teachers between the ages of 21-60 years Female instructors and college professors between the ages of 21-60 years - A score of = 15 on factor 1 of the VFI (tiredness and avoidance of voice use) or a score of = 5 on factor 3 of the VFI (improvement of symptoms or lack thereof with rest) - Sedentary- wherein participants will need to be completing mild intensity cardiovascular exercise less than 150 minutes in less than 5 days per week Exclusion Criteria: - Trained athletes - Trained singers - Smoking in the past 6months - Prior history of a vocal fold pathology and current vocal fold pathology

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cardiovascular Conditioning Protocol
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Other:
Voice Production Exercises
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.

Locations

Country Name City State
United States East Tennessee State University Johnson City Tennessee

Sponsors (1)

Lead Sponsor Collaborator
East Tennessee State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Physiologic Cost of Speaking Physiologic Cost of Speaking is measured as the rate of oxygen consumption at steady state/ rate of speech (wpm) for each of the two reading tasks At baseline, at 4 weeks after treatment
Primary Changes in Oxygen Uptake Kinetics Oxygen Uptake Kinetics is measured as the pattern of oxygen use during each of the two reading tasks At baseline, at 4 weeks after treatment
Primary Changes in Post Task Physiological Recovery Post Task Physiological Recovery is measured as the time, seconds, to reach baseline of oxygen consumption post task (within 0.2ml/kg/min) following each of the reading tasks At baseline, at 4 weeks after treatment
Primary Changes in Excess Post Exercise Consumption (EPOC) EPOC is measured as the magnitude of recovery oxygen consumption, ml/kg/min for each of the reading tasks At baseline, at 4 weeks after treatment
Primary Changes in Ratings of Perceived Exertion (RPE) Borg Scale of Ratings of Perceived Exertion (RPE)- measures the self-report of vocal effort for each of the reading tasks At baseline, at 4 weeks after treatment
Primary Changes in Vocal Fatigue Index (VFI) Vocal Fatigue Index (VFI) is a retrospective scale that measures self-reported symptoms of vocal fatigue At baseline, at 4 weeks after treatment
Primary Changes in Global Rating of Vocal Fatigue (VAS 100mm) Global Rating of Vocal Fatigue (VAS 100mm) measures the ability to sustain voice with no fatigue at the end of a working day At baseline, at 4 weeks after treatment
See also
  Status Clinical Trial Phase
Recruiting NCT05243134 - The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
Completed NCT02486874 - Clinical Evaluation of PoreSkin Phase 1
Active, not recruiting NCT04592640 - Stem Cells for Uremic Calciphylaxis Patients N/A
Recruiting NCT04599686 - Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer N/A
Recruiting NCT03351842 - Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% Phase 2
Completed NCT02782442 - Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) N/A
Completed NCT03439930 - The Effect of Balance Training on Neuromuscular Control in Subjects With CAI N/A
Not yet recruiting NCT05537155 - Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery N/A
Recruiting NCT02971982 - PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia Phase 1/Phase 2
Completed NCT02820272 - Water for Reducing Pain in Negative Pressure Wound Therapy Phase 2
Completed NCT00984958 - Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure N/A
Completed NCT00575224 - Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9 Phase 4
Completed NCT00164307 - Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships Phase 1/Phase 2
Completed NCT00164528 - Intervening With Children/Adolescents With FAS/ARND Phase 1/Phase 2
Recruiting NCT04603586 - Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses N/A
Recruiting NCT03375424 - Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany N/A
Not yet recruiting NCT04062370 - Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion Phase 4
Not yet recruiting NCT02931136 - Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging Phase 4
Completed NCT04661228 - Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)
Recruiting NCT03365141 - Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo N/A